What type of study is this?

This is a Animal Study study (also classified as: In Vitro Study).

What question did this study set out to answer?

This research focuses on developing a KIR3DL2-directed CAR T cell therapy for T cell malignancies.

December 8, 2025Blood

KIR3DL2-directed CAR T cell therapy for T cell malignancies

View Full Paper

Ask AI

Bookmark

Authors

XCXiaoyun ChengThe University of Texas MD Anderson Cancer Center LRLubna RehmanThe University of Texas MD Anderson Cancer Center MRMatthew RichardThe University of Texas MD Anderson Cancer Center

Discussion

Member takes

Implication

CAR T cell therapy demonstrates effective tumor regression in Sézary syndrome and other T cell malignancies, suggesting a novel immunotherapy approach.

Key Points

This research focuses on developing a KIR3DL2-directed CAR T cell therapy for T cell malignancies.
Developed a novel murine monoclonal antibody targeting KIR3DL2 via hybridoma technology.
Engineered a scFv-based CAR construct and tested its efficacy in vitro and in vivo.
Evaluated CAR T cell activity against KIR3DL2-positive T cell lymphoma cell lines in xenograft models.
Anti-KIR3DL2 CAR T cells exhibited significant cytotoxic activity against KIR3DL2-positive cell lines.
In vivo studies showed complete tumor regression in xenograft mouse models with prolonged disease control.
No toxicity or weight loss observed in treated animals.

Cite This Study

Cheng et al. (2025) studied this question.

synapsesocial.com/papers/69362f604fa91c937236dcfe https://doi.org/10.1182/blood-2025-7621

View Full Paper

Ask AI

Bookmark

Implication

CAR T cell therapy demonstrates effective tumor regression in Sézary syndrome and other T cell malignancies, suggesting a novel immunotherapy approach.

KIR3DL2-directed CAR T cell therapy for T cell malignancies

Discussion

Member takes

Implication

Key Points

Cite This Study

KIR3DL2-directed CAR T cell therapy for T cell malignancies

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider